CS logo
small CS logo
Centrum Medyczne PROMED

Krakow, Poland

About Centrum Medyczne PROMED


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centrum Medyczne PROMED


During the past decade, Centrum Medyczne PROMED conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centrum Medyczne PROMED" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Pfizer" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored and "Nutricia Research" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne PROMED" #1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Centrum Medyczne PROMED


According to Clinical.Site data, the most researched conditions in "Centrum Medyczne PROMED" are "Ulcerative Colitis" (3 trials), "Arthritis, Psoriatic" (2 trials), "Colitis, Ulcerative" (2 trials), "Crohn's Disease" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Centrum Medyczne PROMED" in a lesser frequency.

Clinical Trials Intervention Types at Centrum Medyczne PROMED


Most popular intervention types in "Centrum Medyczne PROMED" are "Drug" (20 trials), "Other" (6 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Guselkumab" (7 trials), "Abrocitinib 200 mg" (2 trials), "Golimumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Centrum Medyczne PROMED


The vast majority of trials in "Centrum Medyczne PROMED" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Centrum Medyczne PROMED


Currently, there are NaN active trials in "Centrum Medyczne PROMED". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Centrum Medyczne PROMED, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Medyczne PROMED, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".